Clinical Trials on Neoplasms, Glandular and Epithelial in Australia

Total 4434 results

Novartis Pharmaceuticals

Terminated

To Evaluate the Safety, Local Tolerability, PK and PD of LDE225 on Sporadic Superficial and Nodular Skin Basal Cell Carcinomas (sBCC)

Sporadic Superficial and Nodular Skin Basal Cell Carcinomas

Austria, Australia
South Metropolitan Health Service
Telix Pharmaceuticals (Innovations) Pty Limited

Completed

Phase I Study to Evaluate the Diagnostic Performance of 89Zirconium Girentuximab PET in Urothelial Cancer Patients (ZiPUP)

Urothelial Carcinoma

Australia
Telix International Pty Ltd

Recruiting

131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2) (IPAX-2)

Glioblastoma | Glioblastoma Multiforme | Neoplastic Disease

Australia, Austria, Netherlands, New Zealand
Professor Michael Bourke

Recruiting

Upper GI Outcomes Following EMR (UGI-EMR)

Adenoma, Villous

Australia
Professor Michael Bourke

Active, not recruiting

Comparison Between White Light Endoscopy and Bright Narrow Band Imaging in Diagnosis Colonic Adenomas. (WLEvB-NBI)

Colonic Adenomas

Australia
Austin Health

Unknown

Study of RAD001 in Advanced Cholangiocarcinoma: RADiChol (RADiChol)

Cholangiocarcinoma

Australia
Professor Michael Bourke

Recruiting

Outcomes of Endoscopic Resection of Mucosal and Submucosal Lesions in the Stomach (OERS)

Adenoma, Villous

Australia
Telix International Pty Ltd

Completed

131I-IPA and Concurrent XRT in Recurrent GBM (IPAX-1)

Glioblastoma Multiforme

Austria, Australia, Netherlands
Professor Michael Bourke

Recruiting

Long-term Outcomes of Endoscopic Resection (ER) of Lesions of the Duodenum and Ampulla (OERDA)

Adenoma, Villous

Australia
Australasian Gastro-Intestinal Trials Group
AstraZeneca; Wayne Elphinstone Research Fund

Not yet recruiting

Phase II Study of the Combination of Durvalumab (MEDI4736) (PDL1 Inhibitor) and Olaparib (PARP Inhibitor) in Advanced Cholangiocarcinoma After Initial Chemotherapy and Durvalumab (BIL-PPP)

Cholangiocarcinoma

Australia
Medical University of Vienna
Medical University of Graz; Medical University Innsbruck; Krankenhaus Barmherzige... and other collaborators

Terminated

Topical Imiquimod Versus Conization to Treat Cervical Intraepithelial Neoplasia (ITIC2)

Cervical Intraepithelial Neoplasia

Austria
Medical University of Vienna

Completed

ITIC (Imiquimod Therapy in Cervical Intraepithelial Neoplasia)-Trial (ITIC)

Cervical Intraepithelial Neoplasia

Austria
Galderma R&D

Completed

Metvix PDT in Participant With "High Risk" Basal Cell Carcinoma

Basal Cell Carcinoma

Australia
Professor Michael Bourke

Completed

Non-invasive Risk Stratification of CR AMN/SSP (FIT)

Adenomatous Polyps

Australia
Myeloid Therapeutics

Recruiting

Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors (MYE Symphony)

Epithelial Tumors, Malignant

Australia
Melbourne Health
AnHeart Therapeutics Inc.; Walter and Eliza Hall Institute of Medical Research

Recruiting

A Study of AB-218 in Patients With IDH1 Mutated Low Grade Glioma (AB-218-IIT-201)

Glioma

Australia
Peter MacCallum Cancer Centre, Australia

Terminated

Phase 0 of 18F FPM Using PET/CT in Patients With a Variety of Malignancies

Squamous Cell Carcinoma

Australia
Novartis Pharmaceuticals

Terminated

Everolimus Post Pazopanib Treatment in Metastatic or Advanced Renal Cell Carcinoma (CATChEz)

Carcinoma, Renal Cell

Australia, Korea, Republic of
Western Sydney Local Health District

Completed

Prediction of Dysplasia Within Sessile Serrated Polyps Using Endoscopic Imaging; a Prospective Observational Study (SERRESH)

Sessile Serrated Adenoma

Australia
Western Sydney Local Health District

Recruiting

The Australian Colonic Large Sessile Lesion Endoscopic Resection Study (ACE)

Colon Adenoma | Colon Polyp

Australia
Peplin

Completed

Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Superficial Basal Cell Carcinoma

Basal Cell Carcinoma

Australia
Professor Michael Bourke

Completed

Soft Coagulation for the Prevention of Adenoma Recurrence (SCAR)

Colonic Adenomas

Australia
Peter MacCallum Cancer Centre, Australia

Completed

MYPHISMO: MYB and PD-1 Immunotherapies Against Multiple Oncologies Trial (MYPHISMO)

Adenoid Cystic Carcinoma | Colorectal Cancer

Australia
Galderma R&D

Completed

PDT With Metvix 160 mg/g Cream Versus PDT With Placebo Cream in Patients With Primary Nodular Basal Call Carcinoma

Basal Cell Carcinoma

Australia
Austrian Breast & Colorectal Cancer Study Group
Hoffmann-La Roche; Sanofi-Synthelabo

Completed

Preoperative Combined Radiochemotherapy for Patients With Rectal Carcinoma

Rectal Cancer

Austria
Peplin

Completed

Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Nodular Basal Cell Carcinoma

Basal Cell Carcinoma

Australia
Medical University of Graz
Austrian Science Fund (FWF)

Completed

Primary Imiquimod Treatment Versus Surgery for Vulvar Intraepithelial Neoplasia (PITVIN)

Vulvar Intraepithelial Neoplasia

Austria
NuvOx LLC
The Alfred

Completed

The Effects of NVX-108 as a Radiation Sensitizer in Glioblastoma (GBM)

Glioblastoma Multiforme

Australia
Krankenhaus Barmherzige Schwestern Linz
Medical University of Vienna

Completed

TRICIN: Prospective Study on the Efficacy of Single Topical Trichloroacetic Acid (TCA) 85% in the Treatment of Cervical Intraepithelial Neoplasia (CIN 1/2) (TRICIN)

Cervical Intraepithelial Neoplasia Grade 1 | Cervical Intraepithelial Neoplasia Grade 2

Austria
Myeloid Therapeutics

Recruiting

A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC

Hepatocellular Carcinoma

Australia
Novartis Pharmaceuticals

Terminated

Safety, Tolerability, and Efficacy Study of CLL442 in Patients With Cutaneous Squamous Cell Carcinoma in Situ (SCCis)

Cutaneous Squamous Cell Carcinoma in Situ (CSCCis)

Belgium, Australia, United States
Western Sydney Local Health District

Recruiting

Conventional Endoscopic Mucosal Resection Versus Cold Snare Endoscopic Mucosal Resection of Colonic Lateral Spreading Lesions - A Randomised Controlled Trial

Colon Cancer | Colon Adenoma | Adenoma Colon

Australia
Peplin

Completed

PEP005 Gel - Evaluation of the Safety and Efficacy of Ingenol Mebutate Gel on a Superficial Basal Cell Carcinoma on the Trunk or Extremities

Superficial Basal Cell Carcinoma

Australia
Peplin

Completed

Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Cutaneous Squamous Cell Carcinoma In Situ

Carcinoma, Squamous Cell

Australia
Olivia Newton-John Cancer Research Institute
Humanigen, Inc.

Completed

A Trial of KB004 in Patients With Glioblastoma

Glioblastoma

Australia
PharmAbcine

Active, not recruiting

TTAC-0001 and Pembrolizumab Combination phase1b Trial in Recurrent Glioblastoma

Recurrent Glioblastoma

Australia
South West Sydney Local Health District

Unknown

Drug Monitoring of Sorafenib in Patients With Advanced Hepatocellular Carcinoma (DOSE-HEP)

Hepatocellular Cancer

Australia
Trans Tasman Radiation Oncology Group

Active, not recruiting

Weekly Cetuximab/RT Versus Weekly Cisplatin/RT in HPV-Associated Oropharyngeal Squamous Cell Carcinoma (HPVOropharynx)

HPV Positive Oropharyngeal Squamous Cell Carcinoma

Australia, New Zealand
Gilead Sciences

Terminated

Efficacy Study of CYT997 in Combination With Carboplatin in Glioblastoma

Glioblastoma Multiforme

Australia
Western Sydney Local Health District

Recruiting

A Randomized Comparison Between White Light Endoscopy (WLE) and Bright Narrow Band Imaging (B-NBI) in the Diagnosis of Right Sided Colonic Polyps in Asymptomatic Subjects Undergoing Screening Colonoscopy (WLEvsB-NBI)

Adenoma Colon

Australia
Nativis, Inc.

Completed

A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM) in Australia

Glioblastoma Multiforme

Australia
GC Cell Corporation

Not yet recruiting

Phase 1 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-201

Breast Cancer | Gastric Cancer | Gastroesophageal Junction Adenocarcinoma

Australia
Graceway Pharmaceuticals, LLC

Completed

Open-label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% Cream

Superficial Basal Cell Carcinoma

Australia, New Zealand
Kepler University Hospital

Recruiting

Immuno-Positron Emission Tomography (PET)-Glioma Study, a Proof-of-principle Imaging Study

Glioblastoma

Austria
Blaze Bioscience Inc.

Completed

Safety Study of BLZ-100 in Adult Subjects With Glioma Undergoing Surgery

Glioma

United States, Australia
Peter MacCallum Cancer Centre, Australia

Recruiting

Hepatocellular Carcinoma Imaging Using PSMA PET/CT (HepaSMART)

Hepatocellular Carcinoma

Australia
Medical University of Vienna

Completed

Pembrolizumab Plus Docetaxel for the Treatment of Recurrent or Metastatic Head and Neck Cancer

Head and Neck Carcinoma

Austria
National University Hospital, Singapore
KK Women's and Children's Hospital; National Cancer Centre, Singapore; Australia...

Unknown

Vinorelbine in Relapsed Platinum Resistant or Refractory C5 High Grade Serous, Endometrioid, or Undifferentiated Primary Peritoneum, Fallopian Tube or Ovarian Cancer

Ovarian Cancer | Fallopian Tube Cancer

Singapore, Australia
Western Sydney Local Health District

Not yet recruiting

Cold Snare Endoscopic Mucosal Resection (EMR) vs Cold EMR With Margin Snare Tip Soft Coagulation (STSC)

Colon Cancer | Colon Adenoma | Colorectal Polyp

Australia
Sanofi

Completed

Docetaxel in Non Small Cell Lung Cancer (NSCLC)

Carcinoma, Squamous Cell

Austria

3

Subscribe